IGC Pharma, Inc. Quarterly Operating Lease, Payments in USD from Q2 2020 to Q2 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
IGC Pharma, Inc. annual/quarterly Operating Lease, Payments history and growth rate from Q2 2020 to Q2 2022.
  • IGC Pharma, Inc. Operating Lease, Payments for the quarter ending June 30, 2022 was $26K, a 3.7% decline year-over-year.
  • IGC Pharma, Inc. annual Operating Lease, Payments for 2023 was $140K, a 18.6% increase from 2022.
  • IGC Pharma, Inc. annual Operating Lease, Payments for 2022 was $118K, a 8.26% increase from 2021.
  • IGC Pharma, Inc. annual Operating Lease, Payments for 2021 was $109K, a 38% increase from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2022 $26K -$1K -3.7% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-05
Q2 2021 $27K +$8K +42.1% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-11
Q2 2020 $19K Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.